BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8326704)

  • 1. [Treatment of ocular toxoplasmosis. Part 1: Basic principles and diagnosis].
    Mittelviefhaus H
    Kinderarztl Prax; 1993 May; 61(3):90-6. PubMed ID: 8326704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children.
    Faucher B; Garcia-Meric P; Franck J; Minodier P; Francois P; Gonnet S; L'ollivier C; Piarroux R
    J Infect; 2012 Jan; 64(1):104-9. PubMed ID: 22051915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The problems of congenital ocular toxoplasmosis (author's transl)].
    Vojtová O; Kouba K; Vedrová D
    Klin Monbl Augenheilkd; 1973 Dec; 163(6):732-8. PubMed ID: 4788871
    [No Abstract]   [Full Text] [Related]  

  • 5. Longitudinal study of new eye lesions in treated congenital toxoplasmosis.
    Phan L; Kasza K; Jalbrzikowski J; Noble AG; Latkany P; Kuo A; Mieler W; Meyers S; Rabiah P; Boyer K; Swisher C; Mets M; Roizen N; Cezar S; Remington J; Meier P; McLeod R;
    Ophthalmology; 2008 Mar; 115(3):553-559.e8. PubMed ID: 17825418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical course of congenital toxoplasmosis in children].
    Jankowska H; Szczepańska-Putz M
    Pol Tyg Lek; 1992 Mar 2-9; 47(9-10):228-31. PubMed ID: 1437825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxoplasmosis and ocular pathology].
    Schnyder CC
    Schweiz Med Wochenschr Suppl; 1995; 65():82S-88S. PubMed ID: 7716457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of congenital toxoplasmosis. Clinical and biological results (author's transl)].
    Couvreur J; Nottin N; Desmonts G
    Ann Pediatr (Paris); 1980 Dec; 27(10):647-52. PubMed ID: 7212550
    [No Abstract]   [Full Text] [Related]  

  • 9. [Congenital toxoplasmosis retinochoroiditis after primary infection of the mother in pregnancy].
    Kuchar A; Hayde M; Steinkogler FJ
    Ophthalmologe; 1996 Apr; 93(2):190-3. PubMed ID: 8652987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin].
    Colin J; Harie JC
    J Fr Ophtalmol; 1989; 12(3):161-5. PubMed ID: 2695556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and therapy of congenital toxoplasmosis].
    Friese K; Weigel M; Melchert F
    Geburtshilfe Frauenheilkd; 1994 Aug; 54(8):M99-101. PubMed ID: 7982543
    [No Abstract]   [Full Text] [Related]  

  • 12. Late cerebral relapse of congenital toxoplasmosis.
    Robinson RO; Baumann RJ
    Arch Dis Child; 1980 Mar; 55(3):231-2. PubMed ID: 7387168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
    Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
    Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clindamycin therapy of suspected toxoplasmosis retinochoroiditis].
    Mittelviefhaus H
    Klin Monbl Augenheilkd; 1992 Feb; 200(2):123-7. PubMed ID: 1533697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
    McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
    Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of clindamycin in the treatment of ocular toxoplasmosis].
    Jeddi A; Azaiez A; Bouguila H; Kaoueche M; Malouche S; Daghfous F; Ayed S
    J Fr Ophtalmol; 1997; 20(6):418-22. PubMed ID: 9296037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Difficulties in the diagnosis and treatment of toxoplasmosis].
    Morales Castillo ME; Cedillo Rivera R
    Bol Med Hosp Infant Mex; 1982 May; 39(5):361-6. PubMed ID: 7104080
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ocular toxoplasmosis in 1989].
    Bloch-Michel E
    Bull Soc Belge Ophtalmol; 1989; 230():53-8. PubMed ID: 2488435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fansidar in the treatment of toxoplasmosis].
    Michalová K; Ríhová E; Havlíková M
    Cesk Slov Oftalmol; 1996 Jul; 52(3):173-8. PubMed ID: 8768475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular impairment of toxoplasmosis.
    Antoniazzi E; Guagliano R; Meroni V; Pezzotta S; Bianchi PE
    Parassitologia; 2008 Jun; 50(1-2):35-6. PubMed ID: 18693554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.